Castillejos-López Manuel, Torres-Espíndola Luz Maria, Huerta-Cruz Juan Carlos, Flores-Soto Edgar, Romero-Martinez Bianca S, Velázquez-Cruz Rafael, Higuera-Iglesias Anjarath, Camarena Ángel, Torres-Soria Ana Karen, Salinas-Lara Citlaltepetl, Fernández-Plata Rosario, Alvarado-Vásquez Noé, Solís-Chagoyán Héctor, Ruiz Víctor, Aquino-Gálvez Arnoldo
Departamento de Epidemiología y Estadística, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Life (Basel). 2022 Sep 6;12(9):1384. doi: 10.3390/life12091384.
The SARS-CoV-2 pandemic has confirmed the apocalyptic predictions that virologists have been making for several decades. The challenge the world is facing is that of trying to find a possible treatment, and a viable and expedient option for addressing this challenge is the repurposing of drugs. However, in some cases, although these drugs are approved for use in humans, the mechanisms of action involved are unknown. In this sense, to justify its therapeutic application to a new disease, it is ideal, but not necessary, to know the basic mechanisms of action involved in a drug's biological effects. This review compiled the available information regarding the various effects attributed to Ivermectin. The controversy over its use for the treatment of COVID-19 is demonstrated by this report that considers the proposal unfeasible because the therapeutic doses proposed to achieve this effect cannot be achieved. However, due to the urgent need to find a treatment, an exhaustive and impartial review is necessary in order to integrate the knowledge that exists, to date, of the possible mechanisms through which the treatment may be helpful in defining safe doses and schedules of Ivermectin.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行证实了病毒学家几十年来一直做出的世界末日般的预测。世界面临的挑战是试图找到一种可能的治疗方法,而应对这一挑战的一个可行且便捷的选择是重新利用药物。然而,在某些情况下,尽管这些药物已被批准用于人类,但所涉及的作用机制尚不清楚。从这个意义上说,为了证明其在新疾病中的治疗应用是合理的,了解药物生物学效应所涉及的基本作用机制是理想的,但并非必要条件。本综述汇编了有关伊维菌素各种作用的现有信息。这份报告表明了关于其用于治疗2019冠状病毒病(COVID-19)的争议,该报告认为该提议不可行,因为为实现这一效果所提议的治疗剂量无法达到。然而,由于迫切需要找到一种治疗方法,有必要进行详尽且公正的综述,以便整合迄今为止关于该治疗方法可能发挥作用的机制的现有知识,从而确定伊维菌素的安全剂量和用药方案。